Annual Congress on Mental Health July 09-10, 2018 Conference Venue: Holiday Inn – Marne La Vallée Paris, France

 It is a service to help people recover from the difficulties of longer-term mental health problems. It helps and support people who still find it difficult to cope with everyday life or get on with other people. It aims to help people deal with problems, to get their confidence back, and to help people to live as independently as possible. Rehabilitation specialist expertise in  long-term treatment and care of people with severe mental illness and complex needs. They look at the long-term possibilities for the patient, not just symptoms of the illness, and work closely within a team of other professionals. The rehabilitation team includes psychiatrists, nurses, occupational therapists, psychologists and social workers.

Management and treatment of mental health issues includes all the distinctive courses in which somebody with an emotional sickness can inspire minimize the impacts of the disease. Numerous individuals recognized with emotional instability accomplish quality and recuperation through taking an interest in individual or gathering treatment. Numerous sorts of treatment alternatives are accessible. There is no treatment that works for each person. They can pick either single treatment or blend of medications that works best. The diverse medications incorporate Medication, Complementary, Psychotherapy, Case administration, Alternative Medicine and some more. Advancements in the scope of proof based meds, treatments and psycho-social administrations, for example, psychiatric restoration, lodging, vocation and associate backings have made prosperity and recuperation a reality for individuals living with emotional wellness conditions.

Psychopharmacology has become a major approach to treatment in primary mental health disorders. However, combined psychiatric and medical illness can give rise to some challenging diagnostic problems. Furthermore, drug treatment of patients with such illnesses can involve important drug-disease interactions and drug-drug interactions. One should keep in mind the issues that arise when an emotionally troubled patient would benefit from a psychotropic drug but a concurrent medical illness complicates this treatment. An awareness of both the medical and psychiatric issues involved may make successful treatment possible.

There is definitely a need for further research in the field, especially regarding major unresolved issues such as the proper selection of patients for whom antidepressants are indicated, clinical and biological predictors of treatment response, and the development of new treatments with superior efficacy and safety. Meanwhile, an empathic psychotherapeutic alliance coupled with careful clinical and pharmacological monitoring are the essential prerequisites for successful treatments.

The advancements of psychotherapeutic drugs has enabled management of mental illness and other neurological problems in the general population, without requiring hospitalization. The success of these drugs in controlling symptoms has led to their widespread use in the vulnerable population of pregnant women as well, where the potential embryotoxicity of the drugs has to be weighed against the potential problems of the maternal neurological state. A thorough discussion of animal research and human clinical studies is used to determine the risk associated with the use of each drug category. The direction of future research using psychotherapeutic drugs should more closely parallel the methodology developed in the animal laboratories, especially since these models have already been used extremely successfully in specific instances in the investigation of neurotoxic agents.